Blackrock Health Sciences Trust

BlackRock Health Sciences Trust and Saba Capital Management have entered into a standstill agreement, limiting Saba's actions and requiring them to vote in line with the Board's recommendations until 2027.

A BlackRock Health Sciences Trust portfolio manager reported routine vesting and disposition of common stock and phantom shares on January 30, 2026.

H. Erin Xie, a Portfolio Manager at BlackRock Health Sciences Trust, reported the sale of common stock and the grant and vesting of phantom shares as part of a pre-arranged 10b5-1 plan.

Portfolio Manager Erin Xie H reports transactions involving common stock and phantom shares of BlackRock Health Sciences Trust on January 31, 2025.

Portfolio Manager Liu Xiang reports the acquisition and disposal of common stock and phantom shares in BlackRock Health Sciences Trust on January 31, 2025.

Christopher Accettella, a Portfolio Manager at BlackRock Health Sciences Trust, reports transactions involving common stock and phantom shares of BME on January 31, 2025.

Kyle McClements, a Portfolio Manager at BlackRock Health Sciences Trust, reports transactions involving common stock and phantom shares, including acquisitions, disposals, and vesting of phantom shares.

BlackRock's closed-end funds are holding a joint virtual annual meeting on July 22, 2026, to elect nominees to their Boards of Directors/Trustees.

BlackRock Closed-End Funds will hold a virtual joint annual meeting of shareholders on July 11, 2025, to vote on the election of board nominees.

BlackRock Closed-End Funds will hold a virtual joint annual meeting of shareholders on July 26, 2024, to vote on the election of Board Nominees.